EU Makes ISO Format Mandatory For Side-Effect Reporting From June 2022
New Standard Offers Improved Quality Of Data Collected
Executive Summary
Based on the operational experience gained using the new international standard for reporting suspected adverse reactions in EudraVigilance, the EU has decided to set a date for its mandatory use.
You may also be interested in...
EU To Tighten Up Some Pharmacovigilance Requirements
The European Commission is consulting on a range of proposals to overhaul a nine-year-old regulation on drug safety reporting procedures.
Danish Agency To Buy New Pharmacovigilance System
Rather than develop a new drug safety monitoring system from scratch, the Danish Medicines Agency is looking for a readymade solution.
EU Extends Pilot Of New Drug Safety Reporting System
Testing of the enhanced EU drug safety reporting system, EudraVigilance, is to be extended beyond February in an effort to gain more information on how stakeholders are finding the new requirements.